Therapeutic Advances in Medical Oncology（医学肿瘤学的治疗进展杂志）影响因子_期刊投稿发表

期刊简介

Therapeutic Advances in Medical Oncology delivers the highest quality peer-reviewed original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of cancer. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in medical oncology, providing an online forum for rapid dissemination of recent research and perspectives in this area.The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be followed (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). Therapeutic Advances in Medical Oncology conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.The journal adheres to a blind review process in which the reviewer’s name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; and Online First publication is usually within 3 weeks of Acceptance.

《医学肿瘤学治疗进展》是一本开放获取、同行评审期刊，提供最高质量的文章、综述和学术评论，介绍癌症医学治疗方面的开创性努力和创新研究。该杂志以临床和药理学为重点，面向肿瘤医学的临床医生和研究人员，为发表该领域最高质量的文章提供了印刷和在线论坛。该杂志是出版伦理委员会（ COPE ）的成员。

《Therapeutic Advances in Medical Oncology》期刊已被查看：次

分区信息